These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 20169426

  • 1. Brucellosis: a rare cause of febrile neutropenia in acute myeloblastic leukemia.
    Ozbalci D, Ergene U, Cetin CB.
    Med Oncol; 2011 Mar; 28(1):255-7. PubMed ID: 20169426
    [Abstract] [Full Text] [Related]

  • 2. [An unusual cause of febrile neutropenia: brucellosis].
    Solmaz S, Asma S, Ozdoğu H, Yeral M, Turunç T.
    Mikrobiyol Bul; 2014 Oct; 48(4):669-73. PubMed ID: 25492662
    [Abstract] [Full Text] [Related]

  • 3. Bilateral ear Sweet's syndrome in a case with relapse acute myeloblastic leukemia.
    Disel U, Paydas S, Yavuz S, Tuncer I, Alpay R.
    Leuk Res; 2006 Mar; 30(3):364. PubMed ID: 16157374
    [No Abstract] [Full Text] [Related]

  • 4. Brucella melitensis: a rare cause of febrile neutropenia.
    Citak EC, Arman D.
    Pediatr Hematol Oncol; 2011 Feb; 28(1):83-5. PubMed ID: 20863159
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and Cladribine.
    Wiedower E, Jamy O, Martin MG.
    Anticancer Res; 2015 Nov; 35(11):6287-90. PubMed ID: 26504064
    [Abstract] [Full Text] [Related]

  • 14. Use of cytarabine and idarubicin in a newly diagnosed AML patient with a severe wound.
    Bozoglan H, Ergene U, Yoleri L.
    Transfus Apher Sci; 2011 Aug; 45(1):17-20. PubMed ID: 21727029
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
    Yalman N, Sarper N, Devecioğlu O, Anak S, Eryilmaz E, Can M, Yenilmez H, Ağaoğlu L, Gedikoğlu G.
    Turk J Pediatr; 2000 Aug; 42(3):198-204. PubMed ID: 11105617
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial.
    Zhou X, Mei C, Zhang J, Lu Y, Lan J, Lin S, Zhang Y, Kuang Y, Ren Y, Ma L, Wei J, Ye L, Xu W, Li K, Lu C, Jin J, Tong H.
    Hematol Oncol; 2020 Oct; 38(4):531-540. PubMed ID: 32469434
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.